Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STIMULATE study: Simvastatin influence on DDAVP upregulation of von Willebrand factor and factor VIII
2009-017060-17Phase 4Active
- Sponsor
- Academic Medical Center
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of simvastatin in Type 1 von Willebrand disease and hemophilia A, sponsored by Academic Medical Center. Primary endpoints: Changes in von Willebrand factor antigen after DDAVP during simvastatin therapy, Changes in von Willebrand factor activity after DDAVP during simvastatin therapy and 1 more. Started Nov 2009; status: active.
02
Drugs
simvastatin
03
Conditions
Type 1 von Willebrand diseasehemophilia A
Beyond the preview
Go deeper on 2009-017060-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017060-17.